Zhejiang Haisen Pharmaceutical Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE1000061L9
CNY
22.79
-0.73 (-3.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
122.31
117.46
150.45
108.31
93.48
114.90
113.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
122.31
117.46
150.45
108.31
93.48
114.90
113.00
Raw Material Cost
69.52
67.41
89.63
64.60
54.93
71.60
65.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.09
0.08
0.09
0.09
0.09
0.09
0.01
Selling and Distribution Expenses
12.47
8.85
15.51
7.82
10.18
6.30
7.91
Other Expenses
0.75
0.87
0.92
0.55
0.67
0.36
0.63
Total Expenditure (Excl Depreciation)
89.62
85.06
114.46
78.04
71.87
81.63
79.82
Operating Profit (PBDIT) excl Other Income
32.7
32.400000000000006
36
30.299999999999997
21.6
33.3
33.199999999999996
Other Income
1.96
3.89
9.48
3.12
6.82
6.02
6.58
Operating Profit (PBDIT)
39.33
41.21
46.32
38.05
31.99
42.79
41.69
Interest
0.09
0.08
0.09
0.09
0.09
0.09
0.01
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
52.79
50.05
60.82
43.71
38.55
43.30
47.37
Depreciation
4.94
4.94
4.69
4.69
3.80
3.80
3.88
Profit Before Tax
34.31
36.19
41.53
33.26
28.10
38.90
37.80
Tax
4.72
4.98
5.92
4.35
3.45
5.51
5.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.58
31.21
35.61
28.91
24.66
33.38
32.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.58
31.21
35.61
28.91
24.66
33.38
32.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.58
31.21
35.61
28.91
24.66
33.38
32.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,398.38
1,380.54
1,344.15
1,302.97
1,274.14
1,283.09
1,249.33
Earnings per share (EPS)
0.09
0.21
0.24
0.19
0.17
0.22
0.22
Diluted Earnings per share
0.09
0.21
0.24
0.19
0.17
0.22
0.22
Operating Profit Margin (Excl OI)
26.52%
27.57%
21.37%
27.91%
22.86%
28.69%
27.64%
Gross Profit Margin
32.09%
35.01%
30.72%
35.04%
34.12%
37.16%
36.88%
PAT Margin
24.19%
26.57%
23.67%
26.69%
26.38%
29.05%
28.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 30.80% vs 9.87% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 19.84% vs 18.75% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 48.41% vs 24.14% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Zhejiang Haisen Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
122.31
0
122.31
Other Operating Income
0.00
0.00
0.00
Total Operating income
122.31
0
122.31
Raw Material Cost
69.52
0
69.52
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.09
0
0.09
Selling and Distribution Expenses
12.47
0
12.47
Other Expenses
0.75
0.00
0.75
Total Expenditure (Excl Depreciation)
89.62
0
89.62
Operating Profit (PBDIT) excl Other Income
32.68
0.00
32.68
Other Income
1.96
0
1.96
Operating Profit (PBDIT)
39.33
0
39.33
Interest
0.09
0
0.09
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
52.79
0
52.79
Depreciation
4.94
0
4.94
Profit Before Tax
34.31
0
34.31
Tax
4.72
0
4.72
Provisions and contingencies
0
0
0.00
Profit After Tax
29.58
0
29.58
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
29.58
0
29.58
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.58
0
29.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,398.38
0
1,398.38
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
26.52%
0%
0.00
26.52%
Gross Profit Margin
32.09%
0%
0.00
32.09%
PAT Margin
24.19%
0%
0.00
24.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 12.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.09% vs -21.93% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 30.80% vs 9.87% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.96 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -5.13% vs -12.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 19.84% vs 18.75% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.74 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.27% vs 1.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 48.41% vs 24.14% in Jun 2024

Quarterly - Interest
Interest 0.01 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.52%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024